Intrexon Corporation

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8484
 
  
 
C07K PEPTIDES 4294
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3960
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 37218
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2772
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 19119
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 17108
 
  
 
C07D HETEROCYCLIC COMPOUNDS 15147
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13193
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS741

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0335,351 BIOLOGICAL PRODUCTION OF MULTI-CARBON COMPOUNDS FROM METHANEJul 13, 17Nov 23, 17[C12P, C12N]
2017/0312,315 Engineered Dendritic Cells and Uses for the Treatment of CancerMay 10, 17Nov 02, 17[A61K, C12N, G01N, C07K]
2017/0291,934 IMPROVED THERAPEUTIC CONTROL OF HETERODIMERIC AND SINGLE CHAIN FORMS OF INTERLEUKIN-12Sep 21, 15Oct 12, 17[A61K, C12P, G01N, C07K]
2017/0275,600 MODIFIED FORMS OF PSEUDOMONAS EXOTOXIN AApr 06, 17Sep 28, 17[A61K, C12N, C07K]
2017/0260,244 Endoplasmic Reticulum Localization SignalsMar 06, 17Sep 14, 17[C12N, A01K, C07K]
2017/0204,079 Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor ComplexJan 31, 17Jul 20, 17[C07D, C07C]
2017/0191,027 Methods and Compositions For Treating DiseaseJan 27, 17Jul 06, 17[C12N]
2017/0096,672 Novel Ecdysone Receptor/Invertebrate Retinoid X Receptor-Based Inducible Gene Expression SystemOct 04, 16Apr 06, 17[C12N, C07K]
2016/0311,879 SINGLE CHAIN IL-12 NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOFDec 17, 14Oct 27, 16[C07K]
2016/0176,983 INTERCALATED SINGLE-CHAIN VARIABLE FRAGMENTSDec 16, 15Jun 23, 16[G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9802936 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complexOct 09, 07Oct 31, 17[C12Q, C07F, C07D, C07C, C07K]
9745603 Biological production of multi-carbon compounds from methaneJun 24, 16Aug 29, 17[C12P, C12N]
9724430 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereofSep 24, 15Aug 08, 17[C07H, A61K, C12N, A01K]
9675642 Engineered dendritic cells and uses for the treatment of cancerJan 09, 13Jun 13, 17[A61K, C07H, C12N, G01N, A01K, C07K]
9617317 Endoplasmic reticulum localization signalsSep 11, 15Apr 11, 17[C12N, A01K, C07K]
9604913 Crystalline diacylhydrazine and the use thereofOct 21, 14Mar 28, 17[A61K, A01N, C07C]
9605316 Methods and compositions for diagnosing diseaseNov 23, 15Mar 28, 17[A61K, C12Q, C12N]
9598355 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexOct 09, 14Mar 21, 17[A61K, A01N, C12N, C07D, C07C]
9512148 Boron-containing diacylhydrazinesJul 22, 15Dec 06, 16[C07F]
9492482 Engineered cells expressing multiple immunomodulators and uses thereofOct 08, 09Nov 15, 16[A61K, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0145,520 METHODS AND COMPOSITIONS FOR DIAGNOSING DISEASEAbandonedDec 05, 16May 25, 17[C12Q, C12N]
2015/0275,232 Site-Specific Serine Recombinases and Methods of Their UseAbandonedApr 16, 15Oct 01, 15[C12N]
2014/0322,812 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression SystemAbandonedApr 24, 14Oct 30, 14[C12N]
2013/0276,156 Multiple Inducible Gene Regulation SystemAbandonedSep 13, 12Oct 17, 13[C12N]
2013/0232,588 Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression SystemAbandonedSep 14, 12Sep 05, 13[C12N, C07K]
2013/0195,800 Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses ThereofAbandonedMar 23, 11Aug 01, 13[A61K, C12N]
2012/0185,954 Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene ExpressionAbandonedNov 04, 11Jul 19, 12[C07H, C12N, A01K, A01H, C07K]
2012/0114,620 Engineered Dendritic Cells and Uses for the Treatment of CancerAbandonedSep 01, 11May 10, 12[A61K, C12N, G01N, A61P]
2011/0247,090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene ExpressionAbandonedApr 02, 10Oct 06, 11[C07H, C12N, A01K]
2011/0201,075 OPTOINJECTION METHODSAbandonedDec 17, 10Aug 18, 11[C12N]
2010/0179,310 GENETIC ANALYSIS OF CELLSAbandonedJan 08, 10Jul 15, 10[C07H, C12Q, G01N]
2010/0003,226 Methods and Compositions for Treating DiseaseAbandonedJul 26, 07Jan 07, 10[A61K]
2009/0181,458 Tubulo-vesicular structure localization signalsAbandonedDec 04, 07Jul 16, 09[C12N, C07K]
2009/0170,727 METHODS FOR DYNAMIC VECTOR ASSEMBLY OF DNA CLONING VECTOR PLASMIDSAbandonedMay 18, 05Jul 02, 09[C12N, C40B]
2009/0136,465 Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses ThereofAbandonedSep 29, 08May 28, 09[A61K]
2009/0098,055 Methods and Compositions for Diagnosing DiseaseAbandonedAug 25, 08Apr 16, 09[C12Q, A61B]
2009/0095,985 Multi-layer electrode, cross point memory array and method of manufacturing the sameAbandonedJun 05, 08Apr 16, 09[H01L]
2008/0050,808 DNA modular cloning vector plasmids and methods for their useAbandonedSep 22, 05Feb 28, 08[C12N]
2007/0269,875 Method and apparatus for cell permeabilizationAbandonedFeb 27, 07Nov 22, 07[C12N, C12M]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.